Thompson Davis & Co’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
$13K Buy
+145
New +$12.8K 0.03% 420
2017
Q4
Sell
-853
Closed -$124K 1247
2017
Q3
$124K Buy
853
+80
+10% +$10.9K 0.22% 104
2017
Q2
$100K Buy
773
+43
+6% +$5.27K 0.16% 132
2017
Q1
$91K Buy
730
+110
+18% +$13.2K 0.13% 153
2016
Q4
$72K Sell
620
-186
-23% -$20.7K 0.12% 184
2016
Q3
$84K Hold
806
0.15% 156
2016
Q2
$79K Sell
806
-80
-9% -$8.28K 0.13% 169
2016
Q1
$89K Sell
886
-641
-42% -$66K 0.13% 164
2015
Q4
$183K Buy
1,527
+891
+140% +$103K 0.26% 99
2015
Q3
$69K Sell
636
-358
-36% -$44.4K 0.1% 207
2015
Q2
$115K Sell
994
-23
-2% -$2.63K 0.13% 177
2015
Q1
$117K Sell
1,017
-138
-12% -$16.5K 0.14% 160
2014
Q4
$129K Buy
1,155
+335
+41% +$35.3K 0.15% 144
2014
Q3
$78K Buy
+820
New +$74K 0.1% 202
2014
Q1
Sell
-128
Closed -$11K 924
2013
Q4
$11K Buy
+128
New +$10.1K 0.02% 445

Other funds holding CELG

Thompson Davis & Co's CELG Position: Q3 2018 in Review

Thompson Davis & Co opened a new position in Celgene Corp (CELG) in Q3 2018: 145 shares worth $13K. The stake represents 0.03% of the portfolio and ranks #420 among its holdings. This is a return to the name: Thompson Davis & Co previously reported a position in CELG as recently as Q3 2017.

Thompson Davis & Co first reported a position in CELG in Q4 2013 and has held it in 15 quarters since. The position peaked at $183K in Q4 2015. 1,364 funds tracked by Wall St. Rank hold CELG as of Q3 2018.

  • Thompson Davis & Co held 145 shares of Celgene Corp worth $13K as of Q3 2018.
  • Celgene Corp was a new Thompson Davis & Co position in Q3 2018.
  • Celgene Corp made up 0.03% of Thompson Davis & Co's portfolio in Q3 2018, its #420 holding.
  • Thompson Davis & Co first reported a position in Celgene Corp in Q4 2013 and has held it in 15 quarters since.
  • Thompson Davis & Co's Celgene Corp position peaked at $183K in Q4 2015.
  • 1,364 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2018.

Based on Thompson Davis & Co's 13F filing for Q3 2018, filed 14 Nov 2018.